[HTML][HTML] Duchenne muscular dystrophy

D Duan, N Goemans, S Takeda, E Mercuri… - Nature Reviews …, 2021 - nature.com
Duchenne muscular dystrophy is a severe, progressive, muscle-wasting disease that leads
to difficulties with movement and, eventually, to the need for assisted ventilation and …

[HTML][HTML] The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review

S Ryder, RM Leadley, N Armstrong… - Orphanet journal of rare …, 2017 - Springer
Abstract Background Duchenne Muscular Dystrophy (DMD) is a rapidly progressive, lethal
neuromuscular disorder, present from birth, which occurs almost exclusively in males. We …

The TREAT‐NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations

CL Bladen, D Salgado, S Monges… - Human …, 2015 - Wiley Online Library
Analyzing the type and frequency of patient‐specific mutations that give rise to Duchenne
muscular dystrophy (DMD) is an invaluable tool for diagnostics, basic scientific research …

The pathogenesis and therapy of muscular dystrophies

S Guiraud, A Aartsma-Rus, NM Vieira… - Annual review of …, 2015 - annualreviews.org
Current molecular genomic approaches to human genetic disorders have led to an
explosion in the identification of the genes and their encoded proteins responsible for these …

[PDF][PDF] International cooperation to enable the diagnosis of all rare genetic diseases

KM Boycott, A Rath, JX Chong, T Hartley… - The American Journal of …, 2017 - cell.com
Provision of a molecularly confirmed diagnosis in a timely manner for children and adults
with rare genetic diseases shortens their" diagnostic odyssey," improves disease …

[HTML][HTML] The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review

SM Szabo, RM Salhany, A Deighton… - Orphanet Journal of …, 2021 - Springer
Background Duchenne muscular dystrophy (DMD) is a severe rare progressive inherited
neuromuscular disorder, leading to loss of ambulation (LOA) and premature mortality. The …

The burden of Duchenne muscular dystrophy: an international, cross-sectional study

E Landfeldt, P Lindgren, CF Bell, C Schmitt, M Guglieri… - Neurology, 2014 - AAN Enterprises
Objective: The objective of this study was to estimate the total cost of illness and economic
burden of Duchenne muscular dystrophy (DMD). Methods: Patients with DMD from …

[HTML][HTML] Clinical outcomes in Duchenne muscular dystrophy: a study of 5345 patients from the TREAT-NMD DMD global database

Z Koeks, CL Bladen, D Salgado… - Journal of …, 2017 - content.iospress.com
Background: Recent short-term clinical trials in patients with Duchenne Muscular Dystrophy
(DMD) have indicated greater disease variability in terms of progression than expected. In …

Current and emerging treatment strategies for Duchenne muscular dystrophy

JK Mah - Neuropsychiatric disease and treatment, 2016 - Taylor & Francis
Duchenne muscular dystrophy (DMD) is the most common form of muscular dystrophy in
childhood. It is caused by mutations of the DMD gene, leading to progressive muscle …

[HTML][HTML] Quantifying the burden of caregiving in Duchenne muscular dystrophy

E Landfeldt, P Lindgren, CF Bell, M Guglieri… - Journal of …, 2016 - Springer
Duchenne muscular dystrophy (DMD) is a rare pediatric neuromuscular disease associated
with progressive muscle degeneration and extensive care needs. Our objective was to …